Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Post by TMAZZ21on Feb 09, 2023 9:29pm
799 Views
Post# 35278639

REFOCUS THE CONVERSATIONS TO PROGRESS

REFOCUS THE CONVERSATIONS TO PROGRESSLet the company do what's its gone do!

Everyone's too focus on the stock price.
At the end of the day it's not for you or me to determine how much it's going to be bought out for!
It's up to Pfizer or Roche

So everyone is throwing numbers out there, how about if we just focus on the progress and where this company current at!

If Oncolytics can make a big leap to conquering these awful diseases then the buyout will come.
Progress is the key and we should focus on the progress that Oncolytics has been making.

If you don't believe that ONC has been making Progress then move on, why would you hold on to  a company that is not progressing in the right direction!
Doesn't make any sense!!


<< Previous
Bullboard Posts
Next >>